Oncology Companion Diagnostic Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

By Product & Service (Product (Instrument, Consumables, Software), Service), By Technology (Polymerase chain reaction (PCR), Next-generation sequencing (NGS), Immunohistochemistry (IHC), In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), Others), By Disease Type (Breast cancer, Non-small cell lung cancer, Colorectal cancer, Leukemia, Melanoma, Prostate cancer, Others), By End Use (Hospitals, Pathology/Diagnostic laboratory, Academic medical center), By Region, and By Competition

Published	Pages	Publisher	Report code
Nov 2023	179	TechSci Research	ASDR-642607

Published: Nov 2023 - Pages : 179 - Publisher : TechSci Research - Report code : ASDR-642607

1. Agilent Technologies Inc
2. Illumina Inc
3. QIAGEN NV
4. Thermo Fisher Scientific Inc
5. F Hoffmann-La Roche AG
6. ARUP Laboratories Inc
7. Abbott Laboratories Inc
8. Myriad Genetics Inc
9. bioM?rieux SA
10. Invivoscribe Inc

Molecular Oncology Diagnostics Market - Analysis and Forecast, 2024-2033

This report can be of interest as well:

Molecular Oncology Diagnostics Market - Analysis and Forecast, 2024-2033

Published: April, 2025 | Report code: ASDR-675871